AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
VEKLURY has 20.7 points less BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: VEKLURY (veklury.com)
This is a high-substance clinical portal that prioritizes regulatory compliance and data transparency over marketing fluff. Its low BS score reflects the legal necessity of accuracy in pharmaceutical communications. It is essentially a digital version of a clinical package insert.
Implement Organization and MedicalWebPage schema to fix the technical identity gap in the structured data. Add direct outbound links to the ACTT-1 and PINETREE trial publications in peer-reviewed journals to improve proof pathing. Include ClinicalTrials.gov identifiers (NCT numbers) next to study descriptions. Update the ‘3.1 million patients’ metric if more recent data is available beyond January 2024 to maintain temporal relevance.
The site exhibits exceptionally high substance-to-fluff ratios. Body text is saturated with precise clinical data, such as the median recovery time comparison of 10 days vs 15 days and the 87% lower risk of hospitalization for non-hospitalized patients. Headings are functional and data-driven, though some repetition of the ‘5 days faster’ claim exists for emphasis across pages. The presence of specific n-counts, such as ‘1062 adult men and women’ and ’52 out of 402 patients needing a ventilator,’ provides forensic-level substance.
AI crawlers don't scroll, click, or wait — they take whatever the raw HTML gives them. Start your free crawl layer inspection and see whether your site is actually reachable in an AI native environment.
There is zero detectable semantic drift between the homepage and sub-pages. The H1 ‘VEKLURY could help speed up your recovery’ is immediately substantiated on the ‘Results’ page with specific trial cohorts (hospitalized, non-hospitalized, and pediatric). The core value proposition remains anchored in clinical effectiveness and FDA-approved indications throughout the user journey.
Move beyond vague agency reporting and visualize your surgical implementation plan. Order an Executive SEO Strategy and stop relying on superficial keyword tracking.
While the review_count is 0 and proof_links_count is technically 0 in the structured data, the body text functions as a verifiable clinical document. It references specific study parameters and outcomes that are legally mandated for a prescription drug. However, the lack of direct external links to peer-reviewed journals or ClinicalTrials.gov registry numbers within the crawled text sections prevents a perfect score in this pillar.
The proof density is high, with over 10 distinct data points across the four pages analyzed. Verifiable evidence includes the total number of patients treated globally (3.1 million), specific pediatric trial results (58 infants and children), and detailed side effect comparisons against placebo groups. The ratio of evidence to vague assertion is approximately 8:1.
To see how the methodology translates into real diagnostic output, review a full executive level analysis applied to a global fashion retailer. View the Mango Executive SEO Strategy for a concrete example of how structural gaps, semantic weaknesses, and conversion friction are surfaced in practice.
The site uses standard pharmaceutical templates, particularly the ‘Important Safety Information’ and ‘What is VEKLURY?’ sections, which are industry-standard requirements rather than marketing clichés. The value proposition is highly unique to the remdesivir molecule and cannot be copy-pasted onto competitors. Minor point deductions are applied for the repetitive use of industry-standard terms like ‘proven results’ and ‘path to recovery.’
The primary authority gap is technical rather than editorial. The schema_json is null, indicating a lack of structured data to support the brand’s identity as a pharmaceutical authority. However, the content itself references high-authority regulatory bodies (FDA) and provides a clear mechanism for reporting adverse events via MedWatch, which bolsters institutional credibility.
There is no disconnect between marketing tone and demonstrated results. Every claim regarding efficacy, such as the ‘87% lower risk’ or the ‘5 days faster recovery,’ is paired with specific study context, including patient populations and comparison groups (placebo). The site avoids superlative language like ‘miracle’ or ‘breakthrough’ in favor of clinical terminology.
Medical Devices, Pharma & Biotech BS: VEKLURY (veklury.com)
The content perfectly aligns with the Medical Devices, Pharma & Biotech category. It focuses on a specific therapeutic agent, remdesivir, providing FDA-regulated data including clinical trial results, safety information, and pharmacovigilance reporting mechanisms.
Before embeddings, before entities, before retrieval — the crawler must reach the text. Open the Crawlability & Indexation Guide to learn how access failures erase meaning long before interpretation begins.
“The score is driven primarily by the lack of structured data (Identity) and the absence of direct outbound links to external peer-reviewed proof (Trust). The Information Density and Semantic Coherence pillars scored near-perfectly due to the forensic clinical evidence provided in the text.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 26, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at VEKLURY to view the most current version of their content and see directly what the company offers.
